Tissue Heart Valves Cardiovascular Prosthetic Devices Market

DelveInsight’s ‘Tissue Heart Valves/Cardiovascular Prosthetic Devices -Market Insights, Competitive Landscape and Market Forecast - 2026’ report delivers an in-depth understanding of Tissue Heart Valves/Cardiovascular Prosthetic Devices and the historical and forecasted Tissue Heart Valves/Cardiovascular Prosthetic Devices market trends in the US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.


The Tissue Heart Valves/Cardiovascular Prosthetic Devices market report provides an overview of Tissue Heart Valves/Cardiovascular Prosthetic Devices , as well as its PEST Analysis. Additionally, the report provides insight on the Tissue Heart Valves/Cardiovascular Prosthetic Devices market share of the individual Tissue Heart Valves/Cardiovascular Prosthetic Devices devices, current and forecasted Tissue Heart Valves/Cardiovascular Prosthetic Devices market size from 2018 to 2026 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.

Tissue Heart Valves/Cardiovascular Prosthetic Devices Overview

Mechanical heart valve is an artificial heart valve implanted in the patient suffering from diseases such as aortic stenosis or mitral regurgitation. Patients implanted with these devices do not require anticoagulation medication for a long time. Major advantages of tissue heart valves involve easy tolerance by the body and an average life expectancy of more than 15 years. However, their drawback is their durability only up to 10 to 20 years, thereby creating the need for a second replacement surgery.


Study Period: 2018–2026

Geography Covered

  • The US
  • EU5 (Germany, France, Italy, Spain and the United Kingdom)
  • Japan

List of Companies:

  • Medtronic plc (Ireland)
  • Edwards Lifesciences Corporation (U.S.)
  • Boston Scientific Corporation (U.S.)
  • St. Jude Medical, Inc. (an Abbott Laboratories Company) (U.S.)
  • LivaNova PLC (U.K.)
  • Symetis SA (Switzerland)
  • Jenavalve Technology, Inc. (Germany)
  • CryoLife, Inc. (U.S.)
  • TTK Healthcare Limited (India)
  • Colibri Heart Valve, LLC (U.S.)
  • Lepu Medical Technology Co.
  • Ltd. (China)
  • Braile Biomédica (Brazil).

Tissue Heart Valves/Cardiovascular Prosthetic Devices - Competitive Analysis

This segment of the report provides a brief competitive analysis of Tissue Heart Valves/Cardiovascular Prosthetic Devices , to help understand the competition in the market. It gives a comparative understanding of the products based on types of valves.

Tissue Heart Valves/Cardiovascular Prosthetic Devices : Market Segmentation

By Type of Valve           

  • Transcatheter Heart Valve
  • Tissue Heart Valve
  • Mechanical Heart Valve


By Type

  • Aortic valve
  • Mitral valve
  • Pulmonary valve
  • Tricuspid valve


By End user

  • Hospitals
  • Ambulatory surgical centers

Tissue Heart Valves/Cardiovascular Prosthetic Devices : Market Dynamics

Market Drivers

  • Growing geriatric population and the resulting rise in Hypertensive Vascular Disease (HVD) incidence
  • Regulatory approvals for modern and improved prosthetic heart valves, increased government support for cardiac valve studies
  • Increased awareness of HVD


Market Barriers

  • High cost of transcatheter heart valve devices
  • Problems related to these procedures
  • Unfavourable reimbursement scenario for prosthetic heart valves

Tissue Heart Valves/Cardiovascular Prosthetic Devices : Market Analysis

This segment illustrates the market of Tissue Heart Valves / Cardiovascular Prosthetic Devices across 7MM and how the market is expected to rise in the study period (2018 to 2026), at a significant CAGR.

KOL- Views

To keep up with the market trends, we take KOLs and SME’s opinion working in Tissue Heart Valves/Cardiovascular Prosthetic Devices domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Tissue Heart Valves/Cardiovascular Prosthetic Devices market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.

Scope of the Report

  • The report covers the descriptive overview of Tissue Heart Valves/Cardiovascular Prosthetic Devices , explaining its applications, advantages, and limitations, etc.
  • Additionally, an all-inclusive account of the currently available Tissue Heart Valves/Cardiovascular Prosthetic Devices is provided, which will have an impact on the future market of Tissue Heart Valves/Cardiovascular Prosthetic Devices .
  • A detailed review of Tissue Heart Valves/Cardiovascular Prosthetic Devices market; historical and forecasted market size is included in the report, covering devices outreach in the 7MM.
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the Tissue Heart Valves/Cardiovascular Prosthetic Devices market.

Report Highlights

  • The report covers descriptive overview of the Tissue Heart Valves/Cardiovascular Prosthetic Devices , explaining its applications, working mechanism, etc.
  • The report is a comprehensive account of marketed devices present in the Tissue Heart Valves/Cardiovascular Prosthetic Devices market.
  • The report also reviews the detailed global historical and forecasted Tissue Heart Valves/Cardiovascular Prosthetic Devices market including assessing the outreach in 7 MM.
  • The report helps in developing business strategies by understanding trends shaping and driving the Tissue Heart Valves/Cardiovascular Prosthetic Devices market.

Tissue Heart Valves/Cardiovascular Prosthetic Devices Report Key Strengths

  • 6 Years Forecast
  • 7MM Coverage
  • Competitive Landscape
  • PEST Analysis
  • Market Size

Tissue Heart Valves/Cardiovascular Prosthetic Devices Report Assessment

  • Marketed Product profiles
  • Key Products and Key Players
  • Market Drivers and Barriers
  • Market Forecast
  • KOL’S views

Key Questions

Market Insights:

  • What was the Tissue Heart Valves/Cardiovascular Prosthetic Devices market share (%) distribution in 2018 and how it will look like in 2026?
  • What will be the Tissue Heart Valves/Cardiovascular Prosthetic Devices total market Size as well as market Size by devices across the 7MM during the forecast period (2018–2026)?
  • What are the key findings pertaining to the market across 7MM and which country will have the largest Tissue Heart Valves/Cardiovascular Prosthetic Devices market Size during the forecast period (2018–2026)?
  • At what CAGR, the Tissue Heart Valves/Cardiovascular Prosthetic Devices market is expected to grow in 7MM during the forecast period (2018–2026)?
  • What will be the Tissue Heart Valves/Cardiovascular Prosthetic Devices market outlook across the 7MM during the forecast period (2018–2026)?
  • What will be the Tissue Heart Valves/Cardiovascular Prosthetic Devices market growth till 2026 and what will be the resultant market size in the year 2026?
  • How will the market drivers, barriers and future opportunities affect the market dynamics and a subsequent analysis of the associated trends?


Competitive Landscape:

  • What are the current devices available in the Tissue Heart Valves/Cardiovascular Prosthetic Devices market?
  • What is the Tissue Heart Valves/Cardiovascular Prosthetic Devices available in the market, their product description, regulatory milestones, product development activities, research and development activities etc.?
  • How many key players are developing Tissue Heart Valves/Cardiovascular Prosthetic Devices?
  • What are the key collaborations (Industry–Industry), Mergers and acquisitions, licensing activities related to the Tissue Heart Valves/Cardiovascular Prosthetic Devices?
  • What are the key designations that have been granted for the current Tissue Heart Valves/Cardiovascular Prosthetic Devices?
  • What are the global historical and forecasted market of Tissue Heart Valves/Cardiovascular Prosthetic Devices?

1. Key Insights

2. Executive Summary of Tissue Heart Valves/Cardiovascular Prosthetic Devices

3. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Background and Overview

3.1. Introduction

4. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Regulatory Scenario

5. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Reimbursement Scenario

6. Company Profiles

6.1. Medtronic plc

6.1.1. Company Overview

6.1.2. Product Portfolio

6.1.2.1. Product description

6.1.2.2. Regulatory Milestones

6.1.2.3. Research and Development

6.1.2.4. Product Development Activities

6.2. Edwards Lifesciences Corporation

6.2.1. Company Overview

6.2.2. Product Portfolio

6.2.2.1. Product description

6.2.2.2. Regulatory Milestones

6.2.2.3. Research and Development

6.2.2.4. Product Development Activities

Products detail in the report…

7. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Competitive Analysis

8. KOL Views

9. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Market Analysis in 7MM

9.1. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Market Analysis in 7MM by Type of valve (2018–2026)

9.2. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Market Analysis in 7MM by Type (2018–2026)

9.3. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Market Analysis n 7MM by End-users (2018–2026)

10. Country-Wise Market size of Tissue Heart Valves/Cardiovascular Prosthetic Devices in 7MM (2018–2026)

10.1. Market size of Tissue Heart Valves/Cardiovascular Prosthetic Devices in the United States

10.1.1. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Market Analysis in the United State by Type of valve (2018–2026)

10.1.2. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Market Analysis in the United State by Type (2018–2026)

10.1.3. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Market Analysis in the United State by End-users (2018–2026)

10.2. Market size of Tissue Heart Valves/Cardiovascular Prosthetic Devices in France

10.2.1. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Market Analysis in France by Type of valve (2018–2026)

10.2.2. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Market Analysis in France by Type (2018–2026)

10.2.3. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Market Analysis in France by End-users (2018–2026)

10.3. Market size of Tissue Heart Valves/Cardiovascular Prosthetic Devices in Italy

10.3.1. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Market Analysis in Italy by Type of valve (2018–2026)

10.3.2. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Market Analysis in Italy by Type (2018–2026)

10.3.3. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Market Analysis in Italy by End-users (2018–2026)

10.4. Market size of Tissue Heart Valves/Cardiovascular Prosthetic Devices in the UK

10.4.1. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Market Analysis in the UK by Type of valve (2018–2026)

10.4.2. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Market Analysis in the UK by Type (2018–2026)

10.4.3. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Market Analysis in the UK by End-users (2018–2026)

10.5. Market size of Tissue Heart Valves/Cardiovascular Prosthetic Devices in Spain

10.5.1. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Market Analysis in Spain by Type of valve (2018–2026)

10.5.2. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Market Analysis in Spain by Type (2018–2026)

10.5.3. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Market Analysis in Spain by End-users (2018–2026)

10.6. Market size of Tissue Heart Valves/Cardiovascular Prosthetic Devices in Germany

10.6.1. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Market Analysis in Germany by Type of valve (2018–2026)

10.6.2. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Market Analysis in Germany by Type (2018–2026)

10.6.3. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Market Analysis in Germany by End-users (2018–2026)

10.7. Market size of Tissue Heart Valves/Cardiovascular Prosthetic Devices in Japan

10.7.1. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Market Analysis in Japan by Type of valve (2018–2026)

10.7.2. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Market Analysis in Japan by Type (2018–2026)

10.7.3. Tissue Heart Valves/Cardiovascular Prosthetic Devices: Market Analysis in Japan by End-users (2018–2026)

11. Market Dynamic

11.1. Market Drivers

11.2. Market Barriers

12. PEST Analysis

13. Conclusion and Future Perspective

14. Appendix

14.1. Bibliography

14.2. Report Methodology

15. DelveInsight Capabilities

16. Disclaimer

17. About DelveInsight

List of Table

Table 1: Competitive Analysis

Table 2: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in the 7MM (2018–2026)

Table 3: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in the 7MM by Type of Valve (2018–2026)

Table 4: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in the 7MM by Type (2018–2026)

Table 5: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in the 7MM by End-users (2018–2026)

Table 6: Tissue Heart Valves/Cardiovascular Prosthetic Devices in the US Market Analysis (2018–2026)

Table 7: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in the US by Type of Valve (2018-2026)

Table 8: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in the US by Type (2018-2026)

Table 9: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in the US by End-users (2018-2026)

Table 10: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Germany (2018–2026)

Table 11: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Germany by Type of Valve (2018-2026)

Table 12: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Germany by Type (2018-2026)

Table 13: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Germany by End-users (2018-2026)

Table 14: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in France (2018–2026)

Table 15: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in France by Type of Valve (2018-2026)

Table 16: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in France by Type (2018–2026)

Table 17: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in France by End-users (2018–2026)

Table 18: Tissue Heart Valve /Cardiovascular Prosthetic Devices Market Analysis in Spain (2018–2026)       

Table 19: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Spain by Type of Valve (2018–2026)

Table 20: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Spain by Type (2018–2026)

Table 21: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Spain by End-users (2018–2026)

Table 22: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Italy (2018–2026)

Table 23: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Italy by Type of Valve (2018–2026)

Table 24: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Italy by Type (2018–2026)

Table 25: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Italy by End-users (2018–2026)

Table 26: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in the United Kingdom (2018–2026)

Table 27: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in the United Kingdom by Type of Valve (2018–2026)

Table 28: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in the United Kingdom by Type (2018–2026)

Table 29: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in the United Kingdom by End-users (2018–2026)

Table 30: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Japan (2018–2026)

Table 31: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Japan by Type of Valve (2018–2026)

Table 32: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Japan by Type (2018–2026)

Table 33: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Japan by End-users (2018–2026)

List of Figures

Figure 1: Product description of Tissue Heart Valves / Cardiovascular Prosthetic Devices

Figure 2: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in the 7MM (2018–2026)

Figure 3: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in the 7MM by Type of Valve (2018–2026)

Figure 4: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in the 7MM by Type (2018–2026)

Figure 5: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in the 7MM by End-users (2018–2026)

Figure 6: Tissue Heart Valves/Cardiovascular Prosthetic Devices in the US (2018–2026)

Figure 7: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in the US by Type of Valve (2018-2026)

Figure 8: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in the US by Type (2018-2026)

Figure 9: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in the US by End-users (2018-2026)

Figure 10: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Germany (2018–2026)

Figure 11: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Germany by Type of Valve (2018-2026)

Figure 12: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Germany by Type (2018-2026)

Figure 13: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Germany by End-users (2018-2026)

Figure 14: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in France (2018–2026)

Figure 15: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in France by Type of Valve (2018–2026)

Figure 16: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in France by Type (2018–2026)

Figure 17: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in France by End-users (2018–2026)

Figure 18: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Spain (2018–2026)

Figure 19: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Spain by Type of Valve (2018–2026)

Figure 20: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Spain by Type (2018–2026)

Figure 21: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Spain by End-users (2018–2026)

Figure 22: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Italy (2018–2026)

Figure 23: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Italy by Type of Valve (2018–2026)

Figure 24: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Italy by Type (2018–2026)

Figure 25: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Italy by End-users (2018–2026)

Figure 26: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in United Kingdom (2018–2026)

Figure 27: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in the United Kingdom by Type of Valve (2018–2026)

Figure 28: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in the United Kingdom by Type (2018–2026)

Figure 29: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in the United Kingdom by End-users (2018–2026)

Figure 30: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Japan (2018–2026)       

Figure 31: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Japan by Type of Valve (2018–2026)

Figure 32: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Japan by Type (2018–2026)

Figure 33: Tissue Heart Valves/Cardiovascular Prosthetic Devices Market Analysis in Japan by End-users (2018–2026)

Figure 34: Market Drivers

Figure 35: Market Barriers

Medtronic plc (Ireland)

Edwards Lifesciences Corporation (U.S.)

Boston Scientific Corporation (U.S.)

St. Jude Medical, Inc. (an Abbott Laboratories Company) (U.S.)

LivaNova PLC (U.K.)

Symetis SA (Switzerland)

Jenavalve Technology, Inc. (Germany)

CryoLife, Inc. (U.S.)

TTK Healthcare Limited (India)

Colibri Heart Valve, LLC (U.S.)

Lepu Medical Technology Co.

Ltd. (China)

Braile Biomédica (Brazil).

  • Tags:
  • Tissue Heart Valves/Cardiovascular...
  • Tissue Heart Valves/Cardiovascular...
  • Tissue Heart Valves/Cardiovascular...
  • Tissue Heart Valves/Cardiovascular...
  • Tissue Heart Valves/Cardiovascular...
  • Tissue Heart Valves/Cardiovascular...
  • Tissue Heart Valves/Cardiovascular...
  • Tissue Heart Valves/Cardiovascular...
  • Tissue Heart Valves/Cardiovascular...
  • Tissue Heart Valves/Cardiovascular...

Forward to Friend

Need A Quote